Neurobiological pathways to Alzheimer’s disease: Amyloid-beta, TAU protein or both?

Alzheimer’s disease (AD) is a neurodegenerative disease characterized by progressive cognitive decline, including memory loss, behavioral and psychological symptoms and personality changes. The neuropathological hallmarks of AD are the presence of neuritic (senile) plaques (NP) and neurofibrillary t...

Descripción completa

Detalles Bibliográficos
Autores principales: de Paula, Vanessa de Jesus R., Guimarães, Fabiana Meira, Diniz, Breno Satler, Forlenza, Orestes Vicente
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação de Neurologia Cognitiva e do Comportamento 2009
Materias:
Views & Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618972/
https://www.ncbi.nlm.nih.gov/pubmed/29213627
http://dx.doi.org/10.1590/S1980-57642009DN30300003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618972/
https://www.ncbi.nlm.nih.gov/pubmed/29213627
http://dx.doi.org/10.1590/S1980-57642009DN30300003

Ejemplares similares